A study of 15 and 30 mg Doses of CVL-231 (Emraclidine) in people with Schizophrenia
This study is completed in the United States, in Bulgaria, and in Hungary. It focuses on schizophrenia.
In United States
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in the United States, in Bulgaria, and in Hungary. It focuses on schizophrenia.
In United StatesThis study exists to see whether questionnaires and follow-up reports is workable and worth testing more broadly. Researchers are trying to understand whether questionnaires and follow-up reports can better support energy, concentration, and everyday functioning.
In United StatesThis study is completed in the United States. It focuses on ADHD.
In United StatesThis study is completed in the United States. It focuses on ADHD.
In United StatesThis summary needs review. Please check the official study record and contact the research team for details.
In United StatesThis study is looking at whether Centanafadine Hydrochloride can help people with Attention Deficit/Hyperactivity Disorder. Participants receive a study treatment and complete follow-up visits and assessments.
In United StatesThis summary needs review. Please check the official study record and contact the research team for details.
In United StatesThis summary needs review. Please check the official study record and contact the research team for details.
In United StatesThis summary needs review. Please check the official study record and contact the research team for details.
In United StatesThis summary needs review. Please check the official study record and contact the research team for details.
In United StatesThis summary needs review. Please check the official study record and contact the research team for details.
In United StatesThis summary needs review. Please check the official study record and contact the research team for details.
In United StatesHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.